Fibriant BV
Biotechnology Research
Leiden, Zuid-holland, Nl
6 employees
- Employees
- 6
Fibriant BV Overview
- Headquarters
- Leiden, Zuid-holland, Nl
- Website
- www.fibriant.com
- Industry
- Biotechnology Research
- Employees
- 6
- Funding
- 16.2M
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords
About Fibriant BV
Fibrinogen, a natural soluble blood protein, is at the heart of Fibriant’s science, technology and products. The conversion of Fibrinogen, by active Thrombin, into the insoluble Fibrin matrix is a pivotal step in hemostasis, tissue repair and host-defense against infections. In nature Fibrinogen and Fibrin appear in different forms, each form with a specific and unique structure-function profile. This variation in form and function provides Fibriant with many opportunities to create new and improved, customized healthcare solutions based on specific variants of human Fibrinogen and Fibrin. Fibriant has developed a recombinant manufacturing platform to produce different variants of human Fibrinogen as well as active human Thrombin.
Compare Similar Companies to Fibriant BV
Thermo Fisher Scientific
Biotechnology Research
Globus Medical
Medical Equipment Manufacturing
VectorY
Biotechnology Research
LeydenJar
Nanotechnology Research
LAVA Therapeutics N.V.
Biotechnology Research
Allero Therapeutics BV
Biotechnology Research
The Brand Men®
Advertising Services
Amphera B.V.
Biotechnology
AbSano B.V.
Biotechnology Research
Amylon Therapeutics
Biotechnology